Mass drug administration and the sustainable control of schistosomiasis: an evaluation of treatment compliance in the rural Philippines

[1]  R. Olveda,et al.  Praziquantel for the treatment of schistosomiasis during human pregnancy , 2017, Bulletin of the World Health Organization.

[2]  C. King,et al.  Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis , 2017, PLoS neglected tropical diseases.

[3]  M. Dayrit,et al.  Soil-Transmitted Helminthiasis and Schistosomiasis in Children of Poor Families in Leyte, Philippines: Lessons for Disease Prevention and Control , 2017, Journal of tropical pediatrics.

[4]  R. Anderson,et al.  The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission , 2017, Parasites & Vectors.

[5]  A. Kontoleon,et al.  Community-directed mass drug administration is undermined by status seeking in friendship networks and inadequate trust in health advice networks , 2017, Social science & medicine.

[6]  S. Ng,et al.  Risk factors for human helminthiases in rural Philippines. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2016. , 2017, Releve epidemiologique hebdomadaire.

[8]  P. Mwinzi,et al.  Experiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya , 2016, BMC Public Health.

[9]  S. Knopp,et al.  Community Knowledge, Perceptions, and Practices Associated with Urogenital Schistosomiasis among School-Aged Children in Zanzibar, United Republic of Tanzania , 2016, PLoS neglected tropical diseases.

[10]  R. Olveda,et al.  Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. , 2016, The Lancet. Infectious diseases.

[11]  A. Kontoleon,et al.  Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Y. Goto,et al.  SCHISTOSOMIASIS IN THE PHILIPPINES : CHALLENGES AND SOME SUCCESSES IN CONTROL , 2016 .

[13]  S. Knopp,et al.  Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey , 2016, Parasites & Vectors.

[14]  D. Gurarie,et al.  Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa , 2015, Parasites & Vectors.

[15]  A. Elliott,et al.  Uptake of Mass Drug Administration Programme for Schistosomiasis Control in Koome Islands, Central Uganda , 2015, PloS one.

[16]  L. Sandvik,et al.  A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa , 2015 .

[17]  Gail M. Williams,et al.  High Prevalence of Schistosoma japonicum and Fasciola gigantica in Bovines from Northern Samar, the Philippines , 2015, PLoS neglected tropical diseases.

[18]  Gail M. Williams,et al.  Can mass drug administration lead to the sustainable control of schistosomiasis? , 2015, The Journal of infectious diseases.

[19]  Gail M. Williams,et al.  Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications. , 2015, Microbes and infection.

[20]  O. Salawu,et al.  Schistosomiasis transmission; socio-demographic, knowledge and practices as transmission risk factors in pregnant women , 2016, Journal of Parasitic Diseases.

[21]  H. Carabin,et al.  Schistosoma japonicum in Samar, the Philippines: infection in dogs and rats as a possible risk factor for human infection , 2014, Epidemiology and Infection.

[22]  B. Babu,et al.  Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. , 2014, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  A. Kiragga,et al.  Effectiveness of a Pre-treatment Snack on the Uptake of Mass Treatment for Schistosomiasis in Uganda: A Cluster Randomized Trial , 2014, PLoS medicine.

[24]  Gail M. Williams,et al.  Road to the elimination of schistosomiasis from Asia: the journey is far from over. , 2013, Microbes and infection.

[25]  G. Weil,et al.  A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis , 2013, PLoS neglected tropical diseases.

[26]  O. Doumbo,et al.  Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa) , 2013, Infectious Diseases of Poverty.

[27]  F. Nuwaha,et al.  Uptake of Preventive Treatment for Intestinal Schistosomiasis among School Children in Jinja District, Uganda: A Cross Sectional Study , 2013, PloS one.

[28]  E. Matey,et al.  Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project. , 2012, The American journal of tropical medicine and hygiene.

[29]  D. Boakye,et al.  The promise and pitfalls of mass drug administration to control intestinal helminth infections , 2012, Current opinion in infectious diseases.

[30]  L. Leonardo,et al.  A National Baseline Prevalence Survey of Schistosomiasis in the Philippines Using Stratified Two-Step Systematic Cluster Sampling Design , 2012, Journal of tropical medicine.

[31]  Z. Nujum,et al.  Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India. , 2011, International health.

[32]  J. Williamson,et al.  Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs , 2010, PLoS neglected tropical diseases.

[33]  A. Fenwick,et al.  Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme , 2009, Parasitology.

[34]  H. Carabin,et al.  Is mass treatment the appropriate schistosomiasis elimination strategy? , 2008, Bulletin of the World Health Organization.

[35]  Ali Al-Ameri,et al.  National institute for Health and Clinical excellence guidance , 2007 .